[1]
2023. Evaluation of Response to Ritlecitinib Treatment Based on SALT Improvement Scores in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s187. DOI:https://doi.org/10.25251/skin.7.supp.187.